Induction of HMOX1 by mesenchymal stem cell cytotherapy inhibits osteoclastogenesis and myeloma-induced bone disease.

ABSTRACT:

SUBMITTER: Li X 

PROVIDER: S-EPMC12116329 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature